US University studies Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes
University of Virginia is starting a new clinical trial of Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes.
Forty women with type 1 diabetes (age 18-40) using a continuous glucose monitor and an insulin pump will be enrolled for a 3-month data collection. Study participants will include free-cycling women and women following oral contraceptive therapy.
Women, age 18-40 y.o., diagnosed with type 1 diabetes and currently using an insulin pump, will be provided a study continuous glucose monitor (CGM) in order to collect 3 full menstrual cycle data within 180 days. Enrollment may last from 3-5 months.
The inclusion parameters are:
- Type 1 diabetes for at least 12 months.
- Use of glucose sensor in the last 6 months.
- Use of insulin pump in the last 6 months.
- Age ≥18 to ≤40 years.
- Average blood glucose values estimated to be approximately 200mg/dL or less based on blood glucose data, CGM data, or historical medical report within the last 12 months.
- Absence of perimenopausal/menopausal symptoms.
The full list can be viewed at the link below.
The clinical trial started in December 7, 2020 and will continue throughout June 30, 2021.
The contacts and locations are the University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States.
For more details: https://ichgcp.net/clinical-trials-registry/NCT04665999
